Paychex director Joseph M. Velli sells 7,839 shares

A director's reported activity includes both a common-stock sale and compensation awards, with restricted stock units subject to vesting.

Rhea-AI Filing Summary

Paychex Inc. (PAYX) director Joseph M. Velli reported selling 7,839 common shares at $107.68 per share on October 14, 2026. On October 15, he received awards of 4,040 stock options with a $110.78 exercise price and 970 restricted stock units. The restricted stock units are subject to vesting under the Amended and Restated 2002 Stock Incentive Plan; no Rule 10b5-1 plan is reported. The report also lists direct options over 9,615 common shares at a $57.20 exercise price, expiring July 12, 2027, and 8,641 common shares at $70.37, expiring July 11, 2028.

Insider Trade Summary

Net Seller: 7,839 shares

Net Sell 13 txns

Insider VELLI JOSEPH M

Role Director

Sold 7,839 shs ($844K)

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	4,040	$110.78	$448K
Grant/Award	Common Stock F1	970	$0.00	$0.00
Sale	Common Stock	7,839	$107.68	$844K
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 54,584 contracts for 50,544 underlying shares (Direct); Common Stock — 82,695 shares (Direct)

Footnotes (1)

1. F1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

Key Figures

Common shares sold: 7,839 shares Sale price: $107.68 per share Stock options awarded: 4,040 options +3 more

6 metrics

Common shares sold 7,839 shares October 14, 2026

Sale price $107.68 per share October 14, 2026

Stock options awarded 4,040 options October 15, 2026

Exercise price $110.78 per share Options awarded October 15, 2026

Restricted stock units awarded 970 units Subject to vesting; October 15, 2026

Underlying shares in reported option position 9,615 common shares Direct options at a $57.20 exercise price, expiring July 12, 2027

Key Terms

restricted stock units, vesting, exercise price, Amended and Restated 2002 Stock Incentive Plan

4 terms

restricted stock units financial

"970 restricted stock units, subject to vesting"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"subject to vesting under the Amended and Restated 2002 Stock Incentive Plan"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"exercise price of $110.78 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Amended and Restated 2002 Stock Incentive Plan financial

"pursuant to the Amended and Restated 2002 Stock Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PAYX shares did director Joseph M. Velli sell?

Joseph M. Velli, a Paychex Inc. director, reported a direct sale of 7,839 common shares at $107.68 per share on October 14, 2026.

What PAYX awards did Joseph M. Velli receive?

On October 15, 2026, Joseph M. Velli received awards of 4,040 stock options with a $110.78 exercise price per share and 970 restricted stock units. The options have an exercise date of October 15, 2027, and an expiration date of October 14, 2036. The restricted stock units are subject to vesting under the Amended and Restated 2002 Stock Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/16/2026 - 04:00 PM EDT Accepted by SEC EDGAR 10/16/2026 - 04:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VELLI JOSEPH M

(Last) (First) (Middle)

911 PANORAMA TRAIL SOUTH

(Street)

ROCHESTER NEW YORK 14625

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/14/2026		S		7,839	D	$107.68	81,725	D
Common Stock	10/15/2026		A		970(1)	A	$0	82,695	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$110.78	10/15/2026		A		4,040		10/15/2027	10/14/2036	Common Stock	4,040	$110.78	4,040	D
Stock Option	$57.2							07/13/2018	07/12/2027	Common Stock	9,615		9,615	D
Stock Option	$70.37							07/12/2019	07/11/2028	Common Stock	8,641		8,641	D
Stock Option	$85.33							07/11/2020	07/10/2029	Common Stock	7,929		7,929	D
Stock Option	$73.53							07/15/2021	07/14/2030	Common Stock	5,793		5,793	D
Stock Option	$112.67							07/15/2022	07/14/2031	Common Stock	5,075		5,075	D
Stock Option	$115							07/15/2023	07/14/2032	Common Stock	3,027		3,027	D
Stock Option	$120.86							07/15/2024	07/14/2033	Common Stock	3,382		3,382	D
Stock Option	$121.63							07/15/2025	07/14/2034	Common Stock	3,351		3,351	D
Stock Option	$140.68							07/15/2026	07/14/2035	Common Stock	670		670	D
Stock Option	$127.52							10/15/2026	10/14/2035	Common Stock	3,061		3,061	D

Explanation of Responses:

1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

	Todd Card, Attorney-in-fact	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)